Overview
Semaglutide peptide is a long-acting GLP-1 receptor agonist studied for its role in glucose regulation, appetite signaling, and weight management. By mimicking incretin pathways with an extended half-life, Semaglutide serves as a valuable research tool for investigating insulin sensitivity, energy balance, and metabolic health in preclinical models.
Compound Breakdown
Semaglutide (15mg / 30mg): Synthetic GLP-1 receptor agonist analog studied for effects on insulin secretion, satiety, glucose metabolism, and energy expenditure.
Research Applications
- Glucose Regulation → investigated for insulinotropic effects and improvements in glycemic control.
- Weight Management → studied for appetite suppression, satiety signaling, and body composition changes.
- Metabolic Pathways → explored for lipid metabolism, energy expenditure, and long-term metabolic adaptations.
- Comparative Models → evaluated against other GLP-1 receptor agonists (liraglutide, tirzepatide, retatrutide) for differences in potency and duration.
- Endocrine Research → studied in pancreatic β-cell signaling as well as extra-pancreatic GLP-1 receptor pathways.
Related Categories
Semaglutide belongs to the Metabolic and Longevity categories. It is often researched alongside MOTS-c and Tirzepatide in studies of glucose control and metabolic pathways.
Compliance Statement
All Not Labs products are strictly for research use only and are not intended for human or veterinary use.


Reviews
There are no reviews yet.